• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用校准自动凝血酶生成试验±血栓调节蛋白来识别血栓前状态。

Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype.

作者信息

Dargaud Yesim, Trzeciak M Christine, Bordet Jean Claude, Ninet Jacques, Negrier Claude

机构信息

Unite d'Hemostase Clinique- Laboratoire d'Hemostase, Hopital Edouard Herriot, Lyon, France.

出版信息

Thromb Haemost. 2006 Nov;96(5):562-7.

PMID:17080211
Abstract

There is currently no validated method to detect a prothrombotic phenotype. The question remains, can tissue factor (TF) induced thrombin generation (TG), as measured with the calibrated automated thrombinography (CAT) technique, according to Hemker et al., recognise a prothrombotic state either as such, or when the activated protein C (APC)-system is boosted with thrombomodulin (TM)? We determined the normal range of CAT-TG +/- TM in a group of 71 healthy blood donors, in 11 healthy women using oral contraceptives (OC), and in 89 patients with a history of venous thromboembolism (VTE), divided into a group of 50 in which a prothrombotic risk factor could be found (VTEprf+) and 39 others (VTEprf-). The endogenous thrombin potential (ETP) in the OC, VTEprf+ and VTEprf- group was significantly higher than for the controls. In the presence of TM, the differences were significantly higher than in its absence. The VTEprf+ group had a higher ETP, +/- TM than the VTEprf-group. In conclusion, TG, measured with the CAT technique in the presence of TM is capable of detecting the prothrombotic phenotype with a high sensitivity of 0.93 (95% confidence limits 0.82-0.99).

摘要

目前尚无经过验证的方法来检测血栓前状态。问题依然存在,根据Hemker等人的研究,使用校准自动凝血酶生成法(CAT)测量的组织因子(TF)诱导的凝血酶生成(TG),能否识别血栓前状态本身,或者当活化蛋白C(APC)系统通过血栓调节蛋白(TM)增强时?我们确定了71名健康献血者、11名使用口服避孕药(OC)的健康女性以及89名有静脉血栓栓塞(VTE)病史的患者(分为50名可发现血栓前危险因素的患者(VTEprf +)和39名其他患者(VTEprf -))的CAT - TG +/- TM正常范围。OC组、VTEprf +组和VTEprf -组的内源性凝血酶潜力(ETP)显著高于对照组。在存在TM的情况下,差异显著高于不存在TM时。VTEprf +组的ETP(+/- TM)高于VTEprf -组。总之,在存在TM的情况下用CAT技术测量的TG能够以0.93的高灵敏度(95%置信区间0.82 - 0.99)检测血栓前状态。

相似文献

1
Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype.使用校准自动凝血酶生成试验±血栓调节蛋白来识别血栓前状态。
Thromb Haemost. 2006 Nov;96(5):562-7.
2
Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.口服避孕药对通过校准自动血栓形成分析法测定的凝血酶生成的影响。
Thromb Haemost. 2007 Dec;98(6):1350-6.
3
Thrombin generation in patients after acute deep-vein thrombosis.急性深静脉血栓形成患者的凝血酶生成情况。
Thromb Haemost. 2008 Aug;100(2):240-5.
4
Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.患有因子V莱顿突变的静脉血栓栓塞症患者一级亲属的凝血酶生成:一项初步研究。
Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.
5
The endogenous thrombin potential and the risk of venous thromboembolism.内源性凝血酶潜力与静脉血栓栓塞风险
Thromb Res. 2007;121(3):353-9. doi: 10.1016/j.thromres.2007.04.012. Epub 2007 Jun 8.
6
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.因子V莱顿突变携带者及无已知血栓形成风险因素患者的静脉血栓栓塞;复发预测以及活化蛋白C-蛋白C抑制物复合物浓度和/或可溶性血栓调节蛋白抗原及活性
Thromb Res. 2007;121(2):145-51. doi: 10.1016/j.thromres.2007.03.020. Epub 2007 May 11.
7
Thrombin generation as an intermediate phenotype for venous thrombosis.凝血酶生成作为静脉血栓形成的中间表型。
Thromb Haemost. 2010 Jan;103(1):114-22. doi: 10.1160/TH09-06-0356. Epub 2009 Nov 13.
8
Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.健康成人和儿童血浆中的凝血酶生成:发色底物法与荧光底物法血栓图分析
Thromb Haemost. 2007 Sep;98(3):600-13.
9
Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism.凝血酶生成:使用来自健康对照者以及有静脉血栓栓塞病史患者的乏血小板血浆、富血小板血浆和全血样本进行检测的比较
Br J Haematol. 2007 Oct;139(1):106-12. doi: 10.1111/j.1365-2141.2007.06732.x.
10
Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.在高凝或低凝患者中,凝血酶生成以内源性凝血酶潜能来评估。
Haematologica. 2003 May;88(5):547-54.

引用本文的文献

1
Age- and sex-dependency of thrombin generation parameters in the general Italian population: the Moli-sani study.意大利普通人群中凝血酶生成参数的年龄和性别依赖性:莫利萨尼研究
Front Cardiovasc Med. 2025 Feb 21;12:1528871. doi: 10.3389/fcvm.2025.1528871. eCollection 2025.
2
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein C.在凝血酶生成试验中,血栓调节蛋白比活化蛋白C更能有力地指示复方口服避孕药诱导的活化蛋白C途径抵抗。
Front Cardiovasc Med. 2024 Nov 29;11:1490601. doi: 10.3389/fcvm.2024.1490601. eCollection 2024.
3
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.
静脉血栓栓塞相关基因变异、凝血因子水平与凝血酶生成潜能之间的关联。
EJHaem. 2024 Feb 18;5(1):47-54. doi: 10.1002/jha2.863. eCollection 2024 Feb.
4
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.抗磷脂抗体阳性患者的凝血酶生成试验作为一种个体化血栓风险评估:现状与展望。
Curr Rheumatol Rep. 2024 May;26(5):178-187. doi: 10.1007/s11926-024-01140-1. Epub 2024 Feb 19.
5
Editorial: Advances in thrombin generation.社论:凝血酶生成的进展
Front Cardiovasc Med. 2023 Mar 30;10:1183718. doi: 10.3389/fcvm.2023.1183718. eCollection 2023.
6
Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.用于出血和血栓性疾病个性化治疗的凝血酶生成检测。
Front Cardiovasc Med. 2022 Nov 10;9:1033416. doi: 10.3389/fcvm.2022.1033416. eCollection 2022.
7
External validation of the MidiCAT variant of thrombography: Comparison with calibrated automated thrombography and study of the centrifugation scheme.血栓形成检测法MidiCAT变体的外部验证:与校准自动血栓形成检测法的比较及离心方案研究
Front Cardiovasc Med. 2022 Oct 21;9:998687. doi: 10.3389/fcvm.2022.998687. eCollection 2022.
8
Risk stratification for pregnancy-associated venous thromboembolism: Potential role for global coagulation assays.妊娠相关静脉血栓栓塞的风险分层:全血凝固检测的潜在作用。
Obstet Med. 2022 Sep;15(3):168-175. doi: 10.1177/1753495X211025397. Epub 2021 Aug 5.
9
Assessing the individual roles of FII, FV, and FX activity in the thrombin generation process.评估凝血因子II、凝血因子V和凝血因子X活性在凝血酶生成过程中的个体作用。
Front Cardiovasc Med. 2022 Sep 20;9:1000812. doi: 10.3389/fcvm.2022.1000812. eCollection 2022.
10
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.使用含有屈螺酮和雌三醇的避孕药的女性,其凝血酶原生成减少。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):135-143. doi: 10.1210/clinem/dgac511.